Inno-Gene Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Inno-Gene's earnings have been declining at an average annual rate of -35.1%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 3.7% per year.

Anahtar bilgiler

-35.1%

Kazanç büyüme oranı

-34.5%

EPS büyüme oranı

Life Sciences Sektör Büyümesi26.0%
Gelir büyüme oranı3.7%
Özkaynak getirisi-221.4%
Net Marj-1,668.9%
Sonraki Kazanç Güncellemesi08 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Here's Why We Think Inno-Gene (WSE:IGN) Might Deserve Your Attention Today

Jul 25
Here's Why We Think Inno-Gene (WSE:IGN) Might Deserve Your Attention Today

Here's Why We Think Inno-Gene (WSE:IGN) Is Well Worth Watching

Apr 05
Here's Why We Think Inno-Gene (WSE:IGN) Is Well Worth Watching

Here's Why I Think Inno-Gene (WSE:IGN) Is An Interesting Stock

Dec 28
Here's Why I Think Inno-Gene (WSE:IGN) Is An Interesting Stock

Should You Be Adding Inno-Gene (WSE:IGN) To Your Watchlist Today?

Aug 28
Should You Be Adding Inno-Gene (WSE:IGN) To Your Watchlist Today?

We Wouldn't Rely On Inno-Gene's (WSE:IGN) Statutory Earnings As A Guide

Feb 17
We Wouldn't Rely On Inno-Gene's (WSE:IGN) Statutory Earnings As A Guide

Gelir ve Gider Dağılımı

Inno-Gene nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

WSE:IGN Gelir, gider ve kazançlar (PLN Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 240-620
31 Mar 240-120
31 Dec 231-630
30 Sep 232-240
30 Jun 233-260
31 Mar 23-9-6-10
31 Dec 22160120
30 Sep 22240150
30 Jun 22333160
31 Mar 223910150
31 Dec 21306120
30 Sep 2123680
30 Jun 2115540
31 Mar 216120
31 Dec 205010
30 Sep 203110
30 Jun 202010
31 Mar 201010
31 Dec 191010
30 Sep 191-110
30 Jun 192110
31 Mar 193110
31 Dec 183020
30 Sep 183120
30 Jun 183120
31 Mar 183120
31 Dec 173120
30 Sep 174030
30 Jun 174-130
31 Mar 174-230
31 Dec 165-340
30 Sep 165-350
30 Jun 164-340
31 Mar 165-140
31 Dec 154-140
30 Sep 154130
30 Jun 154230
31 Mar 154220
31 Dec 144220
30 Sep 144020
30 Jun 144-120
31 Mar 143-120
31 Dec 133020

Kaliteli Kazançlar: IGN is currently unprofitable.

Büyüyen Kar Marjı: IGN is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: IGN is unprofitable, and losses have increased over the past 5 years at a rate of 35.1% per year.

Büyüme Hızlandırma: Unable to compare IGN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: IGN is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-0.7%).


Özkaynak Getirisi

Yüksek ROE: IGN has a negative Return on Equity (-221.37%), as it is currently unprofitable.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin